 | • レポートコード：MRC23Q35878 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の治験管理システム市場について調査・分析し、世界の治験管理システム市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（エンタープライズCTMS、サイトCTMS）、用途別セグメント分析（製薬＆バイオ医薬品、医療機器、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Oracle、Medidata Solutions、PAREXEL、Bioclinica、IBM、Veeva Systems、ERT、DSG、Forte Research Systems、MedNet Solutions、Bio-Optronics、DATATRAK、MasterControl、DZS Software Solutions、ArisGlobalなどが含まれています。 世界の治験管理システム市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、治験管理システム市場規模を推定する際に考慮しました。本レポートは、治験管理システムの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、治験管理システムに関するビジネス上の意思決定に役立てることを目的としています。 ・治験管理システム市場の概要 - 治験管理システムのタイプ別セグメント - 世界の治験管理システム市場規模：タイプ別分析（エンタープライズCTMS、サイトCTMS） - 治験管理システムの用途別セグメント - 世界の治験管理システム市場規模：用途別分析（製薬＆バイオ医薬品、医療機器、その他） - 世界の治験管理システム市場規模予測（2018年-2029年） ・治験管理システム市場の成長トレンド - 治験管理システムの地域別市場規模（2018年-2029年） - 治験管理システム市場ダイナミクス - 治験管理システムの業界動向 - 治験管理システム市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：エンタープライズCTMS、サイトCTMS - 世界の治験管理システムのタイプ別市場規模（2018年-2023年） - 世界の治験管理システムのタイプ別市場規模（2024年-2029年） ・用途別セグメント：製薬＆バイオ医薬品、医療機器、その他 - 世界の治験管理システムの用途別市場規模（2018年-2023年） - 世界の治験管理システムの用途別市場規模（2024年-2029年） ・治験管理システムの地域別市場規模 - 北米の治験管理システム市場規模（2018年-2029年） - アメリカの治験管理システム市場規模（2018年-2029年） - ヨーロッパの治験管理システム市場規模（2018年-2029年） - アジア太平洋の治験管理システム市場規模（2018年-2029年） - 中国の治験管理システム市場規模（2018年-2029年） - 日本の治験管理システム市場規模（2018年-2029年） - 韓国の治験管理システム市場規模（2018年-2029年） - インドの治験管理システム市場規模（2018年-2029年） - オーストラリアの治験管理システム市場規模（2018年-2029年） - 中南米の治験管理システム市場規模（2018年-2029年） - 中東・アフリカの治験管理システム市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Oracle、Medidata Solutions、PAREXEL、Bioclinica、IBM、Veeva Systems、ERT、DSG、Forte Research Systems、MedNet Solutions、Bio-Optronics、DATATRAK、MasterControl、DZS Software Solutions、ArisGlobal ・アナリストの観点/結論 ・調査方法とデータソース |
A Clinical Trial Management System (CTMS) is a software system used by biotechnology and pharmaceutical industries to manage clinical trials in clinical research.
Highlights
The global Clinical Trial Management System market was valued at US$ 1387.6 million in 2022 and is anticipated to reach US$ 3126.8 million by 2029, witnessing a CAGR of 14.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Clinical Trial Management System key players include Oracle, Medidata Solutions, PAREXEL, IBM, etc. Global top four manufacturers hold a share nearly 40%.
North America is the largest market, with a share about 50%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Enterprise CTMS is the largest segment, with a share over 70%. And in terms of application, the largest application is Pharmaceutical and Biopharmaceutical Companies, followed by Clinical Research Organizations, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Management System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Management System.
The Clinical Trial Management System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Clinical Trial Management System market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Management System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Oracle
Medidata Solutions
PAREXEL
Bioclinica
IBM
Veeva Systems
ERT
DSG
Forte Research Systems
MedNet Solutions
Bio-Optronics
DATATRAK
MasterControl
DZS Software Solutions
ArisGlobal
Segment by Type
Enterprise CTMS
Site CTMS
Segment by Application
Pharma and Biopharmaceutical
Medical Device
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Management System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Management System Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Enterprise CTMS
1.2.3 Site CTMS
1.3 Market by Application
1.3.1 Global Clinical Trial Management System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharma and Biopharmaceutical
1.3.3 Medical Device
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Management System Market Perspective (2018-2029)
2.2 Clinical Trial Management System Growth Trends by Region
2.2.1 Global Clinical Trial Management System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical Trial Management System Historic Market Size by Region (2018-2023)
2.2.3 Clinical Trial Management System Forecasted Market Size by Region (2024-2029)
2.3 Clinical Trial Management System Market Dynamics
2.3.1 Clinical Trial Management System Industry Trends
2.3.2 Clinical Trial Management System Market Drivers
2.3.3 Clinical Trial Management System Market Challenges
2.3.4 Clinical Trial Management System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Management System Players by Revenue
3.1.1 Global Top Clinical Trial Management System Players by Revenue (2018-2023)
3.1.2 Global Clinical Trial Management System Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Trial Management System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trial Management System Revenue
3.4 Global Clinical Trial Management System Market Concentration Ratio
3.4.1 Global Clinical Trial Management System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Management System Revenue in 2022
3.5 Clinical Trial Management System Key Players Head office and Area Served
3.6 Key Players Clinical Trial Management System Product Solution and Service
3.7 Date of Enter into Clinical Trial Management System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Management System Breakdown Data by Type
4.1 Global Clinical Trial Management System Historic Market Size by Type (2018-2023)
4.2 Global Clinical Trial Management System Forecasted Market Size by Type (2024-2029)
5 Clinical Trial Management System Breakdown Data by Application
5.1 Global Clinical Trial Management System Historic Market Size by Application (2018-2023)
5.2 Global Clinical Trial Management System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clinical Trial Management System Market Size (2018-2029)
6.2 North America Clinical Trial Management System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Clinical Trial Management System Market Size by Country (2018-2023)
6.4 North America Clinical Trial Management System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial Management System Market Size (2018-2029)
7.2 Europe Clinical Trial Management System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Clinical Trial Management System Market Size by Country (2018-2023)
7.4 Europe Clinical Trial Management System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Management System Market Size (2018-2029)
8.2 Asia-Pacific Clinical Trial Management System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Clinical Trial Management System Market Size by Region (2018-2023)
8.4 Asia-Pacific Clinical Trial Management System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial Management System Market Size (2018-2029)
9.2 Latin America Clinical Trial Management System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Clinical Trial Management System Market Size by Country (2018-2023)
9.4 Latin America Clinical Trial Management System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Management System Market Size (2018-2029)
10.2 Middle East & Africa Clinical Trial Management System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Clinical Trial Management System Market Size by Country (2018-2023)
10.4 Middle East & Africa Clinical Trial Management System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Oracle
11.1.1 Oracle Company Detail
11.1.2 Oracle Business Overview
11.1.3 Oracle Clinical Trial Management System Introduction
11.1.4 Oracle Revenue in Clinical Trial Management System Business (2018-2023)
11.1.5 Oracle Recent Development
11.2 Medidata Solutions
11.2.1 Medidata Solutions Company Detail
11.2.2 Medidata Solutions Business Overview
11.2.3 Medidata Solutions Clinical Trial Management System Introduction
11.2.4 Medidata Solutions Revenue in Clinical Trial Management System Business (2018-2023)
11.2.5 Medidata Solutions Recent Development
11.3 PAREXEL
11.3.1 PAREXEL Company Detail
11.3.2 PAREXEL Business Overview
11.3.3 PAREXEL Clinical Trial Management System Introduction
11.3.4 PAREXEL Revenue in Clinical Trial Management System Business (2018-2023)
11.3.5 PAREXEL Recent Development
11.4 Bioclinica
11.4.1 Bioclinica Company Detail
11.4.2 Bioclinica Business Overview
11.4.3 Bioclinica Clinical Trial Management System Introduction
11.4.4 Bioclinica Revenue in Clinical Trial Management System Business (2018-2023)
11.4.5 Bioclinica Recent Development
11.5 IBM
11.5.1 IBM Company Detail
11.5.2 IBM Business Overview
11.5.3 IBM Clinical Trial Management System Introduction
11.5.4 IBM Revenue in Clinical Trial Management System Business (2018-2023)
11.5.5 IBM Recent Development
11.6 Veeva Systems
11.6.1 Veeva Systems Company Detail
11.6.2 Veeva Systems Business Overview
11.6.3 Veeva Systems Clinical Trial Management System Introduction
11.6.4 Veeva Systems Revenue in Clinical Trial Management System Business (2018-2023)
11.6.5 Veeva Systems Recent Development
11.7 ERT
11.7.1 ERT Company Detail
11.7.2 ERT Business Overview
11.7.3 ERT Clinical Trial Management System Introduction
11.7.4 ERT Revenue in Clinical Trial Management System Business (2018-2023)
11.7.5 ERT Recent Development
11.8 DSG
11.8.1 DSG Company Detail
11.8.2 DSG Business Overview
11.8.3 DSG Clinical Trial Management System Introduction
11.8.4 DSG Revenue in Clinical Trial Management System Business (2018-2023)
11.8.5 DSG Recent Development
11.9 Forte Research Systems
11.9.1 Forte Research Systems Company Detail
11.9.2 Forte Research Systems Business Overview
11.9.3 Forte Research Systems Clinical Trial Management System Introduction
11.9.4 Forte Research Systems Revenue in Clinical Trial Management System Business (2018-2023)
11.9.5 Forte Research Systems Recent Development
11.10 MedNet Solutions
11.10.1 MedNet Solutions Company Detail
11.10.2 MedNet Solutions Business Overview
11.10.3 MedNet Solutions Clinical Trial Management System Introduction
11.10.4 MedNet Solutions Revenue in Clinical Trial Management System Business (2018-2023)
11.10.5 MedNet Solutions Recent Development
11.11 Bio-Optronics
11.11.1 Bio-Optronics Company Detail
11.11.2 Bio-Optronics Business Overview
11.11.3 Bio-Optronics Clinical Trial Management System Introduction
11.11.4 Bio-Optronics Revenue in Clinical Trial Management System Business (2018-2023)
11.11.5 Bio-Optronics Recent Development
11.12 DATATRAK
11.12.1 DATATRAK Company Detail
11.12.2 DATATRAK Business Overview
11.12.3 DATATRAK Clinical Trial Management System Introduction
11.12.4 DATATRAK Revenue in Clinical Trial Management System Business (2018-2023)
11.12.5 DATATRAK Recent Development
11.13 MasterControl
11.13.1 MasterControl Company Detail
11.13.2 MasterControl Business Overview
11.13.3 MasterControl Clinical Trial Management System Introduction
11.13.4 MasterControl Revenue in Clinical Trial Management System Business (2018-2023)
11.13.5 MasterControl Recent Development
11.14 DZS Software Solutions
11.14.1 DZS Software Solutions Company Detail
11.14.2 DZS Software Solutions Business Overview
11.14.3 DZS Software Solutions Clinical Trial Management System Introduction
11.14.4 DZS Software Solutions Revenue in Clinical Trial Management System Business (2018-2023)
11.14.5 DZS Software Solutions Recent Development
11.15 ArisGlobal
11.15.1 ArisGlobal Company Detail
11.15.2 ArisGlobal Business Overview
11.15.3 ArisGlobal Clinical Trial Management System Introduction
11.15.4 ArisGlobal Revenue in Clinical Trial Management System Business (2018-2023)
11.15.5 ArisGlobal Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details